OpGen, Curetis, and Ares Genetics have combined their businesses to build stronger diagnostic solutions for severe infections. Read more.

Rapid and comprehensive

molecular diagnostic infectious disease panels, including detection of bacterial co-infections in COVID-19 pneumonia.

A new light on antibiotic resistance

Using the power of genomics and informatics to fight antibiotic-resistant microbes

Acuitas AMR and Lighthouse

Broad antibiotic resistance detection and AMR prediction

ARESdb

AI-powered bioinformatics taking infectious disease testing to the next level

Unyvero

Rapid molecular diagnostic solutions for severe infections in hospitalized patients

Optimizing Genomic Testing for Antibiotic Resistance

Existing tests can take days to identify the correct treatment for a patient’s infection. That’s why caregivers often use broad-spectrum antibiotics as a first defense—but when those drugs are overused, antibiotic-resistant microbes can emerge. OpGen is developing a better way to treat infection while preventing antibiotic resistance. We harness the power of informatics and genomics to identify antimicrobial resistant (AMR) organisms quickly and accurately, with an aim to improve treatment at the patient, hospital, and network level.

700,000

Deaths each year from bacterial infections (WHO)

50,000

Deaths annually in the us & europe from drug-resistant infections

$20 billion

Excess direct healthcare costs in the us from drug-resistant infections

More about preventing antibiotic resistance

Video

CEO Oliver Schacht discusses the new OpGen

Watch Now

In The News

COVID-19 patients at risk for bacterial pneumonia co-infection.

Learn More

Publications

OpGen accurately and reliably predicts antibiotic resistance in comprehensive study

9.28.20
OpGen Announces Successful Completion of Study Collaboration with Karolinska Institutet on Bacterial Co-Infections in COVID-19 Pneumonia Patients and Presents Data on Unyvero HPN Panel at ECCVID 2020 MORE
9.18.20
OpGen, Inc. Announces Notice of Annual Meeting Venue Change MORE
9.16.20
Collaborative Research by OpGen Group Company Ares Genetics and Johns Hopkins Researchers Demonstrates Potential of Next-Generation Sequencing for Investigation of Genetic Antimicrobial Resistance Mechanisms and Molecular Susceptibility Testing MORE

See all news

Upcoming Events

There are currently no upcoming events.

See all events

Latest Blog Posts

9.02.20
A Multiplex Polymerase Chain Reaction Assay for Antibiotic Stewardship in Suspected Pneumonia MORE
7.23.20
New Antibiotics won’t solve the Antibiotic Resistance Crisis, but better Diagnostics could MORE
7.22.20
Assessing the Potential of Short-Read and Long-Read Sequencing to Predict Phenotypic Antimicrobial Susceptibility Testing Results in Carbapenem-Resistant Klebsiella pneumoniae MORE

See blog